Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-03

Clinical Trial Results: Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating relapse prevention and primaquine efficacy for radical cure of vivax malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Primaquine (primaquine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Vivax Malaria | Phase 4 | Status: COMPLETED | Results posted: 2026-06-03